I now have comprehensive data from multiple authoritative sources. Let me compile the full clinical answer.
Heavy Menstrual Bleeding (HMB) in a 40-Year-Old - Clinical Approach
A 40-year-old presenting with heavy menstrual bleeding (HMB) is a very common yet important gynaecological scenario. At this age, peri-menopause, fibroids, adenomyosis, endometrial pathology (including hyperplasia/malignancy), and coagulopathy all enter the differential. Your approach must be systematic.
Step 1 - Clarify Terminology & Definition
HMB (previously called menorrhagia) is defined as excessive menstrual blood loss that interferes with the patient's physical, social, emotional, or material quality of life. Clinically, blood loss >80 mL per cycle is abnormal, and bleeding lasting >7 days is considered excessive. - Rosen's Emergency Medicine
The modern classification system is PALM-COEIN (FIGO, 2011) - this replaces older terms like "dysfunctional uterine bleeding."
| PALM (Structural) | COEIN (Non-structural) |
|---|
| Polyp | Coagulopathy |
| Adenomyosis | Ovulatory dysfunction |
| Leiomyoma (fibroids) | Endometrial causes |
| Malignancy / Hyperplasia | Iatrogenic (medications, IUCD) |
| Not otherwise classified |
- Sabiston Textbook of Surgery; Rosen's Emergency Medicine
Step 2 - History (Targeted)
Bleeding history:
- Cycle length, duration of bleeding, number of pads/tampons soaked
- Passage of clots, flooding, need to double up protection
- Onset - sudden vs. gradual, change from baseline
Associated symptoms:
- Dysmenorrhoea (suggests adenomyosis, fibroids, endometriosis)
- Dyspareunia, pelvic pressure, urinary frequency (fibroids)
- Intermenstrual or postcoital bleeding (polyp, cervical pathology, malignancy)
- Symptoms of anaemia: fatigue, dyspnoea, palpitations
Red flags at 40 years:
- Unexplained weight loss
- Postcoital bleeding
- Irregular / unpredictable bleeding (vs. heavy but regular)
- Family history of colorectal or endometrial cancer
Risk factors for endometrial cancer (must screen for):
- Obesity, PCOS, diabetes, nulliparity, unopposed oestrogen exposure, tamoxifen use, family history of Lynch syndrome
Coagulopathy screen (especially if HMB since menarche):
- History of postpartum haemorrhage, surgical bleeding, easy bruising, epistaxis, dental bleeding, family history of bleeding disorders (von Willebrand disease)
Medication history: OCP, HRT, anticoagulants, IUCDs, tamoxifen
Obstetric history: Parity, desire for future fertility (this directs treatment!)
Step 3 - Physical Examination
- General: Pallor, signs of anaemia, weight/BMI (obesity = endometrial cancer risk)
- Thyroid: Goitre or signs of hypothyroidism
- Skin: Easy bruising, petechiae (coagulopathy)
- Signs of hyperandrogenism: Acne, hirsutism (PCOS)
- Abdominal exam: Uterine/fibroid mass
- Speculum exam: Cervical appearance, polyps, ectropion, trauma
- Bimanual exam: Uterine size, mobility, tenderness, adnexal masses (enlarged, bulky, tender uterus = adenomyosis; irregular, non-tender = fibroids)
Step 4 - Investigations
Mandatory (First Line)
| Investigation | Purpose |
|---|
| Urine pregnancy test | Exclude pregnancy/ectopic (always) |
| FBC (Full blood count) | Assess iron-deficiency anaemia (Hb, MCV) |
| Serum ferritin / iron studies | Iron deficiency (may exist even without anaemia) |
| Thyroid function tests (TFT) | Hypothyroidism is a reversible cause |
| Pelvic ultrasound (TVS preferred) | Fibroids, polyps, adenomyosis, endometrial thickness |
| Cervical smear (if due) | Cervical pathology screening |
- Sabiston; Goldman-Cecil Medicine; NICE NG88
Hormone Panel (Where Indicated)
| Investigation | When |
|---|
| Serum FSH / LH | If perimenopause suspected |
| Serum prolactin | If irregular cycles, galactorrhoea |
| Fasting glucose / OGTT | If PCOS features present |
| Androgens (testosterone, DHEAS) | If signs of hyperandrogenism |
Coagulation Studies (If Clinical Suspicion)
- PT, APTT, platelet count
- von Willebrand factor antigen + activity - screen if HMB since menarche, or family/personal bleeding history
- Goldman-Cecil: CBC, platelet count, and coagulation studies including vWD screening are part of the workup
Endometrial Biopsy - Mandatory at Age 40
This is the most important investigation at this age group. Perform in the following situations (at minimum):
- Any woman ≥45 with AUB - but at 40 with HMB, biopsy is strongly indicated if:
- Obesity, PCOS, anovulatory cycles, unopposed oestrogen exposure
- Persistent or treatment-refractory HMB
- Endometrial thickness >7 mm on USS (in premenopausal)
- Intermenstrual bleeding
Methods:
- Pipelle biopsy (office procedure, first choice)
- Hysteroscopy + biopsy - gold standard when combined (better sensitivity and specificity for endometrial pathology) - Bailey & Love's
At age 40, always rule out endometrial hyperplasia and carcinoma before initiating treatment. - Goldman-Cecil Medicine
Hysteroscopy (Outpatient or Theatre)
- Directly visualises the endometrial cavity
- Allows diagnosis AND removal of polyps and submucosal fibroids in the same sitting
- Combined with biopsy improves sensitivity/specificity - Bailey & Love's
Step 5 - Treatment
Treatment is guided by:
- Underlying cause (PALM-COEIN category)
- Severity of bleeding and anaemia
- Desire for future fertility
- Patient preference
Medical Treatment (First Line for Most)
Non-hormonal options:
| Drug | Mechanism | Use |
|---|
| Tranexamic acid 1g TDS (3-5 days of bleeding) | Antifibrinolytic, reduces blood loss ~50% | Ovulatory HMB, fibroids; safe if fertility desired |
| NSAIDs (Mefenamic acid 500mg TDS during menses) | Reduces prostaglandins, ~30% blood loss reduction | Also helps dysmenorrhoea |
Hormonal options:
| Drug | Notes |
|---|
| Levonorgestrel IUS (Mirena) | First-line hormonal therapy; reduces blood loss by 70-90%; also provides contraception; ideal if no desire for immediate pregnancy |
| Combined OCP | Regulates cycle, reduces blood loss; also provides contraception |
| Cyclic progestogens (Norethisterone 5mg BD day 5-26, or MPA 10mg/day for 10-14 days) | Used in anovulatory / perimenopausal HMB |
| High-dose progestogens (MPA 20-40 mg/day, or norethisterone acetate 10-15 mg/day) | For acute heavy bleed - to stop the episode |
For acute heavy bleeding episode (haemodynamically stable):
- OCP every 6 hours x 5-7 days (off-label) - bleeding should stop within 24 hours
- IV conjugated oestrogens 25 mg every 4 hours (up to 3 doses) + simultaneous progestin
- High-dose oral progestins (MPA 20-40mg/day or norethisterone acetate 10-15mg/day)
- Goldman-Cecil Medicine; FOGSI-ICOG Guidelines
For fibroids (AUB-L):
- GnRH agonists (pre-operative shrinkage)
- Newer agents: Relugolix 40mg daily, Elagolix 300mg BD (GnRH antagonists - reduce fibroid-related bleeding)
- Tranexamic acid + NSAIDs for symptom control
Surgical / Procedural Treatment (Second Line)
| Procedure | Indication |
|---|
| Hysteroscopic polypectomy | Endometrial/cervical polyps |
| Hysteroscopic myomectomy | Submucosal fibroids |
| Endometrial ablation | HMB with no desire for future pregnancy; ~71% success at 5 years (29% eventually need hysterectomy) |
| Uterine artery embolization (UAE) | Symptomatic fibroids, fertility may be preserved; ~31% eventually need hysterectomy |
| Myomectomy (open/laparoscopic) | Fibroids + desire to preserve fertility |
| Hysterectomy | Definitive; reserved for failed medical/conservative therapy, confirmed malignancy, or patient preference; should NOT be done without prior endometrial sampling |
Hysterectomy should be reserved for patients who do not respond to or cannot tolerate medical therapy. Alternatives including endometrial ablation and UAE should be considered first. - Berek & Novak's Gynecology
Treat the Anaemia
- Oral ferrous sulphate 200mg BD-TDS if iron deficient
- IV iron if oral not tolerated or severe deficiency
- Blood transfusion if Hb <7g/dL or haemodynamically compromised
Summary Algorithm for a 40-Year-Old with HMB
1. History + Exam
↓
2. Exclude pregnancy (urine hCG)
↓
3. Labs: FBC, ferritin, TFT, coagulation screen if indicated
↓
4. Pelvic USS (TVS)
↓
5. Endometrial biopsy (Pipelle or hysteroscopy + biopsy) — MANDATORY at this age
↓
6. Identify PALM-COEIN cause
↓
7. Medical therapy first (LNG-IUS preferred / tranexamic acid / OCP / progestin)
↓
8. If failed → Surgical (ablation, hysteroscopic procedure, UAE, myomectomy)
↓
9. Hysterectomy as last resort (or if malignancy confirmed)
Key Points at Age 40
- Always biopsy the endometrium - she is approaching perimenopause, the risk of endometrial hyperplasia and carcinoma rises significantly after 40
- Fibroids peak between 40-50 and are the single most common structural cause at this age
- Perimenopause brings anovulatory cycles with unopposed oestrogen, a key driver of heavy irregular bleeding
- LNG-IUS (Mirena) is NICE-recommended first-line hormonal treatment for HMB without a structural cause
- Do not perform hysterectomy without prior endometrial sampling
- Explore desire for future fertility before any surgical intervention
Sources:
- Goldman-Cecil Medicine, pp. 2555-2556
- Sabiston Textbook of Surgery, 28th Ed
- Berek & Novak's Gynecology, p. 1411
- Bailey & Love's Short Practice of Surgery, 28th Ed, pp. 1605-1606
- Rosen's Emergency Medicine
- NICE Guideline NG88 - Heavy Menstrual Bleeding (last reviewed July 2026)
- FOGSI-ICOG Management of AUB Guidelines 2024